Antisense chemoradioimmunotherapy consisting of anti-POEM characterized by hypermethylated p53, p16, RASSF1A, RAR-b2, BRCA2, H1C1, ESRI1, CDH1, Trbeta1, GSTP1, CCND2 and overexpression of bcl-2, cdc25c, Raf-1 and α8β1 integrin

Saved in:
Bibliographic Details
Published in:Breast cancer research : BCR 2005-05, Vol.7 (Suppl 1)
Main Authors: Giannios, J, Lambrinos, P, Maragudakis, E, Alexandropoulos, N
Format: Article
Language:English
Subjects:
Apoptosis
Breast cancer
Glycine
Integrins
Metastasis
Methylation
Methyltransferases
Tumor proteins
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1465-5411
DOI:10.1186/bcr1247